Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data evaluating DecisionDx-Melanoma’s i31-SLNB test ...

SLNB remains a key staging procedure in clinically node-negative melanoma and provides prognostic information that can guide adjuvant therapy discussions. Current NCCN guidelines recommend discussing ...

Tumours often feature high chromosomal instability. “And chromosomal instability leads to further chromosomal instability,” says Peter Van Loo of The University of Texas MD Anderson Cancer Center's ...

Add Yahoo as a preferred source to see more of our stories on Google. Moffitt Cancer Center researchers have developed ALFA-K, a new tool that they say can predict how cancer cells survive and compete ...

New technologies and innovations are changing the future of melanoma care. Teledermatology and skin screening mobile apps aided by artificial intelligence (AI) diagnostic support could assist in ...

Scientists from the University of Cambridge and their collaborators have developed an algorithm that identifies unique patterns caused by insertions and deletions in tumor DNA. Details of the ...

Remember how that Google neural net learned to tell the difference between dogs and cats? It's helping catch skin cancer now, thanks to some scientists at Stanford who trained it up and then loosed it ...

The predicted protein structure of FNBP1, one of the potential cancer-driving genes. The study predicts that inclusion of the exon (in yellow) helps cancer cells grow and spread. Researchers at the ...